Cargando…

Management, morbidity and mortality of COPD during an 11-year period: an observational retrospective epidemiological register study in Sweden (PATHOS)

BACKGROUND: Chronic obstructive pulmonary disease (COPD) is one of the most common causes of mortality and a major contributor to morbidity. Longitudinal clinical practice data yielding information on the characteristics of the disease, its natural course, and management are limited. AIMS: To invest...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ställberg, Björn, Janson, Christer, Johansson, Gunnar, Larsson, Kjell, Stratelis, Georgios, Telg, Gunilla, Lisspers, Karin H
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2014
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6443109/ https://www.ncbi.nlm.nih.gov/pubmed/24346825 http://dx.doi.org/10.4104/pcrj.2013.00106

Ejemplares similares

Pneumonia and pneumonia related mortality in patients with COPD treated with fixed combinations of inhaled corticosteroid and long acting β(2) agonist: observational matched cohort study (PATHOS)
por: Janson, Christer, et al.
Publicado: (2013)

Prevalence, characteristics and management of frequently exacerbating asthma patients: an observational study in Sweden (PACEHR)
por: Janson, Christer, et al.
Publicado: (2018)

Prevalence and management of severe asthma in primary care: an observational cohort study in Sweden (PACEHR)
por: Larsson, Kjell, et al.
Publicado: (2018)

Health care resource utilization and cost for asthma patients regularly treated with oral corticosteroids – a Swedish observational cohort study (PACEHR)
por: Janson, Christer, et al.
Publicado: (2018)

Factors associated with lung cancer in COPD patients
por: Sandelin, Martin, et al.
Publicado: (2018)

High use of short-acting β(2)-agonists in COPD is associated with an increased risk of exacerbations and mortality
por: Janson, Christer, et al.
Publicado: (2023)

Impact of Comorbidities and Commonly Used Drugs on Mortality in COPD – Real-World Data from a Primary Care Setting
por: Ellingsen, Jens, et al.
Publicado: (2020)

The Impact of Exacerbation Frequency on Clinical and Economic Outcomes in Swedish COPD Patients: The ARCTIC Study
por: Larsson, Kjell, et al.
Publicado: (2021)

Real-world retrospective cohort study ARCTIC shows burden of comorbidities in Swedish COPD versus non-COPD patients
por: Ställberg, Björn, et al.
Publicado: (2018)

Identifying the associated risks of pneumonia in COPD patients: ARCTIC an observational study
por: Janson, Christer, et al.
Publicado: (2018)

Economic burden of COPD in a Swedish cohort: the ARCTIC study
por: Lisspers, Karin, et al.
Publicado: (2018)

Gender differences among Swedish COPD patients: results from the ARCTIC, a real-world retrospective cohort study
por: Lisspers, Karin, et al.
Publicado: (2019)

Treatment Patterns, Socioeconomic Status and Clinical Burden in Mild COPD: A Swedish Real-World, Retrospective Cohort Study, the ARCTIC Study
por: Larsson, Kjell, et al.
Publicado: (2022)

Inhaled corticosteroids and the risk of type 2 diabetes among Swedish COPD patients
por: Ställberg, Björn, et al.
Publicado: (2020)

Predicting Hospitalization Due to COPD Exacerbations in Swedish Primary Care Patients Using Machine Learning – Based on the ARCTIC Study
por: Ställberg, Björn, et al.
Publicado: (2021)

Characterization of secondary care for COPD in Sweden
por: Sundh, Josefin, et al.
Publicado: (2017)

Impact of COPD diagnosis timing on clinical and economic outcomes: the ARCTIC observational cohort study
por: Larsson, Kjell, et al.
Publicado: (2019)

Difference in resistance to humidity between commonly used dry powder inhalers: an in vitro study
por: Janson, Christer, et al.
Publicado: (2016)

Annual and Post-Exacerbation Follow-Up of Asthma Patients in Clinical Practice – A Large Population-Based Study in Sweden
por: Sandelowsky, Hanna, et al.
Publicado: (2022)

Lack of COPD-Related Follow-Up Visits and Pharmacological Treatment in Swedish Primary and Secondary Care
por: Sandelowsky, Hanna, et al.
Publicado: (2022)

Scientific rationale for the possible inhaled corticosteroid intraclass difference in the risk of pneumonia in COPD
por: Janson, Christer, et al.
Publicado: (2017)

Evaluation of the use of Swedish integrated electronic health records and register health care data as support clinical trials in severe asthma: the PACEHR study
por: Franzén, Stefan, et al.
Publicado: (2016)

Clinical COPD Questionnaire score (CCQ) and mortality
por: Sundh, Josefin, et al.
Publicado: (2012)

Oral corticosteroid use, morbidity and mortality in asthma: A nationwide prospective cohort study in Sweden
por: Ekström, Magnus, et al.
Publicado: (2019)

A Cross-Sectional Study Assessing Appropriateness Of Inhaled Corticosteroid Treatment In Primary And Secondary Care Patients With COPD In Sweden
por: Sulku, Johanna, et al.
Publicado: (2019)

Factors influencing pharmacological treatment in COPD: a comparison of 2005 and 2014
por: Sundh, Josefin, et al.
Publicado: (2017)

Pulmonary rehabilitation in COPD – available resources and utilization in Swedish primary and secondary care
por: Sundh, Josefin, et al.
Publicado: (2017)

Neutrophil-to-lymphocyte ratio, blood eosinophils and COPD exacerbations: a cohort study
por: Ellingsen, Jens, et al.
Publicado: (2021)

Availability of pulmonary rehabilitation in primary care for patients with COPD: a cross-sectional study in Sweden
por: Arne, Mats, et al.
Publicado: (2016)

Change in health status in COPD: a seven-year follow-up cohort study
por: Sundh, Josefin, et al.
Publicado: (2016)

Subjective swallowing symptoms and related risk factors in COPD
por: Gonzalez Lindh, Margareta, et al.
Publicado: (2019)

Influence of comorbid heart disease on dyspnea and health status in patients with COPD – a cohort study
por: Giezeman, Maaike, et al.
Publicado: (2018)

Changes in smoking prevalence and cessation support, and factors associated with successful smoking cessation in Swedish patients with asthma and COPD
por: Stegberg, Marcus, et al.
Publicado: (2018)

COPD – do the right thing
por: Sandelowsky, Hanna, et al.
Publicado: (2021)

Need of education for dry powder inhaler storage and retention – a patient-reported survey
por: Norderud Lærum, Birger, et al.
Publicado: (2016)

Prediction of Mortality Using Different COPD Risk Assessments – A 12-Year Follow-Up
por: Athlin, Åsa, et al.
Publicado: (2021)

Exacerbations Predict Severe Cardiovascular Events in Patients with COPD and Stable Cardiovascular Disease–A Nationwide, Population-Based Cohort Study
por: Løkke, Anders, et al.
Publicado: (2023)

2017 Global Initiative for Chronic Obstructive Lung Disease reclassifies half of COPD subjects to lower risk group
por: Högman, Marieann, et al.
Publicado: (2018)

MAIT cell counts are associated with the risk of hospitalization in COPD
por: Pincikova, Terezia, et al.
Publicado: (2022)

Management and Risk of Mortality in Patients Hospitalised Due to a First Severe COPD Exacerbation
por: Janson, Christer, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_antt3u0138bumru7gljlc6k0vi